Bingham, Kathleen S.
Flint, Alastair J.
Mulsant, Benoit H.
Article History
First Online: 5 July 2019
Compliance with Ethical Standards
:
: Kathleen S. Bingham has no disclosures.Alastair J. Flint currently receives grant support from the U.S. National Institutes of Health, the Patient-Centered Outcomes Research Institute, the Canadian Institutes of Health Research, Brain Canada, the Alzheimer’s Association, and AGE-WELL.Benoit H. Mulsant<b>,</b> during the past 5 years, has received: research funding from Brain Canada, the CAMH Foundation, the Canadian Institutes of Health Research, and the US National Institutes of Health (NIH); research support from Bristol-Myers Squibb (medications for a NIH-funded clinical trial), Eli-Lilly (medications for a NIH-funded clinical trial), Pfizer (medications for a NIH-funded clinical trial), Capital Solution Design LLC (software used in a study funded by CAMH Foundation), and HAPPYneuron (software used in a study funded by Brain Canada). He directly own stocks of General Electric (less than $5000).
: This article does not contain any studies with human or animal subjects performed by any of the authors.